December 19, 2003

PALADIN ANNOUNCES 2004 FINANCIAL OUTLOOK AND REVISED 2003 FINANCIAL GUIDANCE
(Also in PDF format)

December 18, 2003

HEALTH CANADA REQUESTS ADDITIONAL INFORMATION ON STATEX^® SR NEW DRUG SUBMISSION
(Also in PDF format)

December 18, 2003

PALADIN ACQUIRES RIGHTS IN CANADA FOR DARVON-N^® FROM ELI LILLY AND COMPANY
(Also in PDF format)

December 17, 2003

NOTICE OF PALADIN LAB'S FINANCIAL OUTLOOK CONFERENCE CALL
(Also in PDF format)

December 10, 2003

HEALTH CANADA REQUESTS ADDITIONAL INFORMATION ON CIRCADIN^® NEW DRUG SUBMISSION
(Also in PDF format)

November 11, 2003

PALADIN AND MEDA ANNOUNCE CANADIAN DISTRIBUTION AGREEMENT FOR CORTIFOAM
(Also in PDF format)

November 6, 2003

PALADIN AND PANGEO PHARMA SIGN DISTRIBUTION AGREEMENT FOR A PORTFOLIO OF PRODUCTS
(Also in PDF format)

October 30, 2003

PALADIN REPORTS THIRD QUARTER RESULTS
(Also in PDF format)

October 27, 2003

NOTICE OF PALADIN LAB'S THIRD QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

October 20, 2003

PALADIN'S CO-FOUNDERS NAMED QUEBEC ENTREPRENEURS OF THE YEAR IN THE HEALTH-CARE/LIFE SCIENCES FIELD
(Also in PDF format)

August 29, 2003

PALADIN RECEIVES FDA ORPHAN DRUG DESIGNATION FOR FIDELINT (DHEA)
(Also in PDF format)

August 6, 2003

PALADIN RECEIVES ORPHAN DRUG DESIGNATION IN EUROPE FOR FIDELIN^® (DHEA)
(Also in PDF format)

July 31, 2003

PALADIN ANNOUNCES SECOND QUARTER RESULTS
(Also in PDF format)

July 29, 2003
NOTICE OF PALADIN LAB'S SECOND QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

July 8, 2003
PALADIN APPOINTS VICE PRESIDENT, BUSINESS DEVELOPMENT
(Also in PDF format)

June 3, 2003
HEALTH CANADA RECOMMENDS EMERGENCY CONTRACEPTIVE PILL, PLAN BT, FOR SWITCH TO NON-PRESCRIPTION STATUS
(Also in PDF format)

May 20, 2003
PALADIN LICENSES VISICOL^® FROM INKINE
(Also in PDF format)

May 7, 2003
PALADIN REPORTS 2003 FIRST QUARTER RESULTS
(Also in PDF format)

May 5, 2003
NOTICE OF PALADIN LABS' FIRST QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

May 1, 2003
PALADIN APPOINTS TWO NEW DIRECTORS TO ITS BOARD
(Also in PDF format)

March 31, 2003
PALADIN TRANSFERS RIGHTS FOR SELECT OTC BRANDS TO PHARMASCIENCE INC.
(Also in PDF format)

February 6, 2003
PALADIN ANNOUNCES RECORD FINANCIAL RESULTS IN 2002
(Also in PDF format)

February 4, 2003
PALADIN LABS ANNOUNCES FOURTH QUARTER AND YEAR-END RESULTS CONFERENCE CALL
(Also in PDF format)